It has the unique combination of growth, improving fundamentals and a strong chart.
When its rivals were taking a difficult stance for justice, it was busy being toxic. Now, that decision will come to haunt it.
It’s growing market share, has strong growth forecasts and a great-looking chart.
It’s come roaring back to life and right on the radar for growth investors.
It soared as the pandemic forced companies to embrace a new normal, but its growth potential is still massive.
It has momentum from the coronavirus pandemic and it’ll probably never be this cheap again.
It’ll rally with a vengeance once the economy starts to recover.
It’s been hot, rebounding 100% from the March lows. The coronavirus may have disrupted production, but demand holds strong.
Business is still booming for this best-in-breed stock.
It’s been one of the few stocks to rally in 2020 but it’s still one of the cheapest large-caps out there.